CanSino Biologics Inc. announced that the New Drug Application (NDA) for its Tetanus, Reduced Diphtheria, and Pertussis (Acellular, Five Components) Combined Vaccine, Adsorbed, has been accepted by China's National Medical Products Administration. This vaccine, known as the Td5cp Adolescent and Adult, is designed as a booster for individuals aged six years and above and was granted Priority Review status in […]















